Determination of 237Np and 239Pu in Urine Using Sector Field Inductively Coupled Plasma Mass Spectrometry (SF-ICP-MS)
Abstract
Measuring 237Np and 239Pu in urine at low levels is important for both biomonitoring and radiological emergency response. Here we report a newly developed and validated analytical method used to determine 237Np and 239Pu in urine by selective retention of Np and Pu from 2mL of urine directly onto TEVA® resin followed by SF-ICP-MS (coupled to a membrane desolvating introduction system) detection. The method provides solid phase extraction of Np/Pu with observed recovery ratios ranging from 89% to 113% and rapid results with limits of detection well below recommended detection guidelines for children and pregnant women (NCRP 161 reference).
Read the paper
Related studies
- Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale
- Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
- Exercise interventions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials
- Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
- Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.